Thomas Keuer
Chief Executive Officer at ARCA BIOPHARMA, INC.
Net worth: 142 148 $ as of 30/04/2024
Thomas Keuer active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ARCA BIOPHARMA, INC. | Chief Executive Officer | 03/04/2024 | - |
| President | 03/04/2024 | - | |
| Chief Operating Officer | 01/12/2014 | 03/04/2024 | |
| Corporate Officer/Principal | 01/10/2006 | 01/12/2014 |
Career history of Thomas Keuer
Former positions of Thomas Keuer
| Companies | Position | Start | End |
|---|---|---|---|
ARCA biopharma, Inc. /Old/
 ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | Chief Operating Officer | - | 29/01/2009 |
| INSMED INCORPORATED | Chief Operating Officer | 01/01/2004 | 01/11/2006 |
| BAXTER INTERNATIONAL INC. | Chief Tech/Sci/R&D Officer | 01/01/1998 | 01/01/2004 |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 01/01/1998 | 01/01/2004 |
Somatogen, Inc.
 Somatogen, Inc. BiotechnologyHealth Technology Somatogen, Inc. develops specialty oxygen therapeutics. It is engaged in the research, clinical development and commercialization of genetically engineered recombinant human hemoglobin-based products. The company is located in Boulder, CO. | Chief Operating Officer | - | - |
Training of Thomas Keuer
| The University of Texas at Austin | Undergraduate Degree |
| Rice University | Graduate Degree |
Statistics
International
| United States | 9 |
Operational
| Chief Operating Officer | 4 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| INSMED INCORPORATED | Health Technology |
| BAXTER INTERNATIONAL INC. | Health Technology |
| ARCA BIOPHARMA, INC. | Health Technology |
| Private companies | 3 |
|---|---|
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | Health Technology |
Somatogen, Inc.
Somatogen, Inc. BiotechnologyHealth Technology Somatogen, Inc. develops specialty oxygen therapeutics. It is engaged in the research, clinical development and commercialization of genetically engineered recombinant human hemoglobin-based products. The company is located in Boulder, CO. | Health Technology |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
- Stock Market
- Insiders
- Thomas Keuer
- Experience
